Are you Dr. Hernandez-Illas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5333 N Dixie Hwy
Suite 110
Fort Lauderdale, FL 33334Phone+1 954-229-7030Fax+1 954-229-0963
Summary
- Dr. Martha (Hernandez) Hernandez-Illas, MD is a rheumatologist in Fort Lauderdale, Florida. She is currently licensed to practice medicine in Florida. She is affiliated with Holy Cross Hospital.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Rheumatology, 2002 - 2004
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2002
- Ponce Health Sciences University School of MedicineClass of 1999
Certifications & Licensure
- FL State Medical License 2003 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 2 citationsOnce-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, ...Clare Buckeridge, Nikolaos Tsamandouras, Santos Carvajal-Gonzalez, Lisa S Brown, Martha Hernandez-Illas
Diabetes, Obesity & Metabolism. 2024-08-01 - 69 citationsLY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomis...Shweta Urva, Tamer Coskun, Mei Teng Loh, Yu Du, Melissa K Thomas
Lancet. 2022-11-26 - 15 citationsSafety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-cont...Jonathan A Robbins, Dereck Tait, Qinlei Huang, Sheri Dubey, Tami Crumley
Ebiomedicine. 2022-08-01